Evidence map›Paper›PMID 39428530›Full record

ArticleInternal medicine (Tokyo, Japan)2025

Ovarian Cancer with TTF-1-positive Giant Pleural Dissemination.

Kazuo Tsuchiya, Risa Suzuki, Ryota Miyamoto, Tomo Tsunoda, Taisuke Ito, Rie Mori, Takuro Akashi, Yoshiyuki Oyama, Masaki Ikeda

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kazuo TsuchiyaDepartment of Respiratory Medicine, Shizuoka Saiseikai General Hospital, Japan.
Risa SuzukiDepartment of Respiratory Medicine, Shizuoka Saiseikai General Hospital, Japan.
Ryota MiyamotoDepartment of Respiratory Medicine, Shizuoka Saiseikai General Hospital, Japan.
Tomo TsunodaDepartment of Respiratory Medicine, Shizuoka Saiseikai General Hospital, Japan.
Taisuke ItoDepartment of Respiratory Medicine, Shizuoka Saiseikai General Hospital, Japan.
Rie MoriDepartment of Respiratory Medicine, Shizuoka Saiseikai General Hospital, Japan.
Takuro AkashiDepartment of Respiratory Medicine, Shizuoka Saiseikai General Hospital, Japan.
Yoshiyuki OyamaDepartment of Respiratory Medicine, Shizuoka Saiseikai General Hospital, Japan.
Masaki IkedaDepartment of Respiratory Medicine, Shizuoka Saiseikai General Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid transcription factor 1 (TTF-1) is primarily expressed in lung and thyroid cancers, but it has also been observed in other cancers. A 60-year-old woman presented with worsening dyspnea, pleural effusion, lung metastases, a right ovarian tumor, and para-aortic intra-abdominal lymph node metastasis. Biopsies from the pleural dissemination revealed TTF-1-positive adenocarcinomas. To confirm the presence of the primary organ, biopsies were performed on a para-aortic intra-abdominal lymph node that ascended from the ovaries. An adenocarcinoma positive for TTF-1 was identified, thus confirming the diagnosis of ovarian cancer. Our findings revealed that TTF-1 positivity does not always signify a lung cancer origin.

Indexed as

AdenocarcinomaOvarian NeoplasmsPleural NeoplasmsTranscription FactorsFemaleHumansLung NeoplasmsLymphatic MetastasisMiddle AgedThyroid Nuclear Factor 1NKX2-1 protein, humanThyroid Nuclear Factor 1Transcription Factorsnon-small-cell lung carcinomaovarian cancerpleural disseminationTTF-1

Identifiers

PMID39428530
PMCPMC12222970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.